Financhill
Back

TransMedics Group Quote, Financials, Valuation and Earnings

Buy
69

TMDX
TransMedics Group

Last Price:
134.88
Seasonality Move:
23.08%

7 Day Trial

ALL ACCESS PASS

$ 7

TransMedics Group Price Quote

$134.88
-0.05 (-0.93%)
(Updated: May 17, 2024 at 3:59 AM ET)

TransMedics Group Key Stats

Buy
69
TransMedics Group (TMDX) is a Buy

Day range:
$133.60 - $136.04
52-week range:
$36.42 - $137.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.05
P/B ratio:
27.87%

Volume:
620.2K
Avg. volume:
1M
1-year change:
80.24%
Market cap:
$4.4B
Revenue:
$241.6M
EPS:
$-0.34

How Much Does TransMedics Group Make?

Is TransMedics Group Growing As A Company?

  • What Is TransMedics Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.33%
  • What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TransMedics Group Stock Price Performance

What Is TransMedics Group 52-Week High & Low?

TransMedics Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TransMedics Group?

  • How Much Debt Does TransMedics Group Have?
    Total long term debt quarterly is $507M
  • How Much Cash Does TransMedics Group Have?
    Cash and short term investments quarterly total is $350.2M
  • What Is TransMedics Group’s Book Value Per Share?
    Book value per share is 4.85

Is TransMedics Group Cash Flow Positive?

  • What Is TMDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.8M
  • What Is TransMedics Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $399.6M
  • What Is TransMedics Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$237.2M

TransMedics Group Return On Invested Capital

  • Is Management Doing A Good Job?
    TMDX return on invested capital is -1.79%
  • What Is TransMedics Group Return On Assets?
    ROA measures how assets are converting to revenues and is -1.65%
  • What Is TMDX Return On Equity?
    ROE is a measure of profitability and is -6.7%

TransMedics Group Earnings Date & Stock Price

TransMedics Group Competitors

TransMedics Group Dividend Yield

Data Unavailable

TransMedics Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3268.62%
Revenue: 133.07% 15.84%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 120.50
Downside from Last Price: -10.69%

Major Shareholders

  • How many TMDX shares are owned by institutional investors?
    310.7M TMDX shares are owned by institutional investors
  • How many TMDX shares are owned by insiders?
    498.6K TMDX shares are owned by insiders